396 related articles for article (PubMed ID: 2963858)
1. Expression of a 33-kDa antigen Tm 1 on lymphocyte surface after modulation of cell surface antigens by IgM monoclonal antibody.
Hara T; Jung LK; Fu SM
J Immunol; 1988 Feb; 140(4):1028-33. PubMed ID: 2963858
[TBL] [Abstract][Full Text] [Related]
2. A polymorphic Fc receptor for mouse IgG2b on human B cells and monocytes.
Holtrop S; Rijke-Schilder GP; Koene RA; Tax WJ
Immunology; 1991 Dec; 74(4):613-20. PubMed ID: 1838352
[TBL] [Abstract][Full Text] [Related]
3. Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems.
Van Lier RA; Boot JH; De Groot ER; Aarden LA
Eur J Immunol; 1987 Nov; 17(11):1599-604. PubMed ID: 2960543
[TBL] [Abstract][Full Text] [Related]
4. Characterization of IgG FcR-mediated proliferation of human T cells induced by mouse and human anti-CD3 monoclonal antibodies. Identification of a functional polymorphism to human IgG2 anti-CD3.
Parren PW; Warmerdam PA; Boeije LC; Capel PJ; van de Winkel JG; Aarden LA
J Immunol; 1992 Feb; 148(3):695-701. PubMed ID: 1530954
[TBL] [Abstract][Full Text] [Related]
5. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
Green-Johnson JM; Szewczuk MR
Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
[TBL] [Abstract][Full Text] [Related]
6. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.
Dang NH; Torimoto Y; Sugita K; Daley JF; Schow P; Prado C; Schlossman SF; Morimoto C
J Immunol; 1990 Dec; 145(12):3963-71. PubMed ID: 1979581
[TBL] [Abstract][Full Text] [Related]
7. Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes.
van Lier RA; Brouwer M; Rebel VI; van Noesel CJ; Aarden LA
Immunology; 1989 Sep; 68(1):45-50. PubMed ID: 2530156
[TBL] [Abstract][Full Text] [Related]
8. Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies.
Stohl W; Posnett DN; Chiorazzi N
J Immunol; 1987 Mar; 138(6):1667-73. PubMed ID: 2950165
[TBL] [Abstract][Full Text] [Related]
9. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
Demanet C; Brissinck J; Van Mechelen M; Leo O; Thielemans K
J Immunol; 1991 Aug; 147(3):1091-7. PubMed ID: 1830596
[TBL] [Abstract][Full Text] [Related]
10. The induction of T cell unresponsiveness by rapidly modulating CD3.
Davis LS; Wacholtz MC; Lipsky PE
J Immunol; 1989 Feb; 142(4):1084-94. PubMed ID: 2521658
[TBL] [Abstract][Full Text] [Related]
11. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
12. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
13. Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies.
Sánchez-Mateos P; Cebrián M; Acevedo A; López-Botet M; De Landázuri MO; Sánchez-Madrid F
Immunology; 1989 Sep; 68(1):72-9. PubMed ID: 2807372
[TBL] [Abstract][Full Text] [Related]
14. Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr mice.
Davignon JL; Cohen PL; Eisenberg RA
J Immunol; 1988 Sep; 141(6):1848-54. PubMed ID: 3262641
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
[TBL] [Abstract][Full Text] [Related]
16. Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells.
Torimoto Y; Sugita K; Weinberg DS; Dang NH; Donahue C; Letvin NL; Schlossman SF; Morimoto C
J Immunol; 1991 Apr; 146(7):2176-84. PubMed ID: 1706389
[TBL] [Abstract][Full Text] [Related]
17. Triggering of co-mitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies.
Carrera AC; Rincón M; Sánchez-Madrid F; López-Botet M; de Landaźuri MO
J Immunol; 1988 Sep; 141(6):1919-24. PubMed ID: 2459196
[TBL] [Abstract][Full Text] [Related]
18. A novel homodimeric molecule involved in human T cell activation.
Kobata T; Yagita H; Matsuda H; Tansyo S; Yakura H; Katagiri M; Okumura K
J Immunol; 1990 Feb; 144(3):830-5. PubMed ID: 1967274
[TBL] [Abstract][Full Text] [Related]
19. Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes.
Damle NK; Doyle LV; Grosmaire LS; Ledbetter JA
J Immunol; 1988 Mar; 140(6):1753-61. PubMed ID: 2964482
[TBL] [Abstract][Full Text] [Related]
20. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes.
Gangemi RM; Swack JA; Gaviria DM; Romain PL
J Immunol; 1989 Oct; 143(8):2439-47. PubMed ID: 2794503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
